The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ovranette 150 micrograms/30 micrograms coated tablets



Pfizer Healthcare IrelandPA0822/094/001

Main Information

Trade NameOvranette 150 micrograms/30 micrograms coated tablets
Active SubstancesEthinyloestradiol
Levonorgestrel
Dosage FormCoated tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/094/001

Group Information

ATC CodeG03AA Progestogens and estrogens, fixed combinations
G03AA07 levonorgestrel and ethinylestradiol

Status

License statusAuthorised
Licence Issued01/04/1984
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back